AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
May 12, 2021
29755_dirs_2021-05-12_8b342ed2-254c-4721-a92a-9c3323a12fe6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-05-11
Reporting Person: Strom Carrie C (SVP & Pres Global Allerg Aesth)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-11 | Common Stock, $0.01 par value | F | 2887 | $116.22 | Disposed | 56104 | Direct |
More from AbbVie Inc.
Earnings Release
2026
Jul 6
Annual Report
2026
Jun 24
Call Transcript
2026
Jun 22
M&A Activity
2026
Jun 22
Call Transcript
2026
Jun 9
Regulatory Filings
2026
Jun 1
Call Transcript
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Call Transcript
2026
May 8